StockIQ.techRevolution Medicines, Inc. (RVMD) Stock Analysis
Free AI-powered analysis and research for Revolution Medicines, Inc. stock
Sector: Healthcare
RVMD snapshot
Data as of 3 Nov 2026 close. Updated daily.
Revolution Medicines, Inc. scores 65/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 82% of its 52-week range, up 226.0% over the past year. Latest reported figures show a profit margin of 0.0% and return on equity of -79.1%.
What is driving the score
- RSI Neutral: +5
- Mixed Trend: +0
- MACD Bullish: +8
- Weak Profit Margin (0.0%): -8
- Strong Liquidity (11.38 Current Ratio): +8
- Negative ROE (-79.1%): -10
- High P/B (15.51): -5
- Strong Long-term Uptrend: +8
- Very Strong Rise (+226.0% over 1 year): +12
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full RVMD report
Revolution Medicines, Inc. (RVMD) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze RVMD Now →📰 Latest Update
Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
Fri, October 30, 2026 at 4:00 PM UTC 4 min read
Revolution Medicines (RVMD) was honored with the "Excellence in Client Partnership Award" by Medicilon, recognizing the company's strong collaboration in drug development. This accolade highlights RVMD's commitment to innovation and effective partnerships, which could enhance its reputation and attract potential investors. Such recognition may signal to the market that RVMD is well-positioned for future growth in the competitive biotech landscape.